Parent-implemented Social Communication Treatment in Autism
NCT ID: NCT05635760
Last Updated: 2025-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
112 participants
INTERVENTIONAL
2022-10-01
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will be among the first examples of fulfilling the promise of Precision Medicine in providing guidance to patients and families with developmental disorders not about whether to receive intervention but which option for intervention to receive in the context of multiple options. This predict-to prescribe approach of autism intervention will likely lead to a paradigm shift in clinical practice and ultimately result in lowering the overall cost and increasing the effectiveness of intervention for autistic children as individuals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parent-implemented Social Communication Treatment in Preschool Children With Autism Spectrum Disorder
NCT05455411
Promoting Transactional Supports to Optimize Social Communication Outcomes for Infants and Their Families
NCT03307057
Early Socioemotional Intervention for Children With Autism Spectrum Disorder in Hong Kong and Mainland China
NCT04658043
Parent Training Program for Preschool Children With Autism Spectrum Disorders
NCT03725644
Effectiveness of Mindfulness-Based Intervention in Reducing Stigma Stress Among Parents of Autistic Children
NCT06975163
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Autism affects 14 per 10,000 (0.14%) children in Hong Kong and 39.23 per 10,000 in Mainland China. Social communication is a challenging domain in autism, and about 29% of autistic preschoolers have severe verbal deficits. Intervention through pharmaceutical means remains elusive, leaving behavioral interventions the most realistic and immediate avenue of intervention. This project will focus on enhancing the cost-effectiveness of behavioral intervention that targets language and communication. The investigators will do so in the context of precision medicine, in which the investigators aim to identify the most cost effective intervention for the individual autistic child.
AIM OF STUDY:
Objective 1: The investigators will first ascertain whether parent-implemented communication intervention taught by a speech therapist in a Group format (up to 8 families learning together) is more effective than intervention learnt by the parents themselves (learning the same materials without the guidance of a therapist) at the study level.
Objective 2: The investigators will examine pre-intervention child and parent variables simultaneously and construct predictive models of response to the two intervention options (group, more costly vs. self-study, less costly) at the individual-child level.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group-based Parent-implemented Social Communication Training
Eight parents learning in a group format and will be taught by a speech therapist online.
Group-based Parent-implemented Social Communication Training
The intervention will be taught by a speech therapist online (approximately 25 hours distributed over 6 months), with up to 8 parents in a group.
Self-learning-based Parent-implemented Social Communication Training
Parents will learn the same materials without the guidance of a therapist.
Self-learning-based Parent-implemented Social Communication Training
Self-learning families will learn the same materials without the guidance of a therapist.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group-based Parent-implemented Social Communication Training
The intervention will be taught by a speech therapist online (approximately 25 hours distributed over 6 months), with up to 8 parents in a group.
Self-learning-based Parent-implemented Social Communication Training
Self-learning families will learn the same materials without the guidance of a therapist.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meet ADOS-2 criteria for autism or autism spectrum.
* Limited spontaneous expressive language, defined as producing two-to-three-word phrases or fewer, i.e., Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) Module 2, Item A1 \> 0.
Exclusion Criteria
* Parent who has severe psychological or neurological conditions prohibiting them from conducting the intervention program at home (restricted to only the parent in the program)
* Children with any other severe developmental problems beyond autism spectrum disorder
24 Months
60 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patrick C. M. Wong
Stanley Ho Professor of Cognitive Neuroscience; Director of Brain and Mind Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick CM Wong, PhD
Role: PRINCIPAL_INVESTIGATOR
Chinese University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shenzhen Research Institute, The Chinese University of Hong Kong
Shenzhen, Guangdong, China
The Chinese University of Hong Kong
Hong Kong, Shatin, Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRFASD-SZ-22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.